NewCo News: Taiwanese Start-up TWi Tries 2-Part Development Approach
By Jennifer Boggs
Friday, July 22, 2011
When formed in 2010, the founders of TWi Biotechnology Inc. always had in mind a two-pronged strategy: going after generic markets to get relatively quick returns while investing in longer-term innovative drug development programs.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.